SciSight Ecosystem
WoS ESCI Q4Scopus Q3SCImago #14,108CAS 4区Diamond OAGold OA

Clinical and Experimental Vaccine Research

Country: Korea, Republic Of•WoS SCIE Quartile: Q4•Scopus SJR: 0.404•SCImago Rank: #14,108•Identifier (ISSN):2287-3651(Print)/2287-366X(Online)•Articles / Year: 37•Estimated Publication Fee (APC): Free (Diamond OA)
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)Q4
1.4
↑ +0.1

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (Hirsch Index)
25

25 papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation Rate4.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
37articles/year
100% Gold OA•88.57% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q4(IF: 1.4)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.00đ
WoS Q4(IF: 1.4)
🔵 Computed
20251.00đ
WoS Q4(IF: 1.3)
🔵 Computed
20241.00đ
WoS Q4(IF: 2.1)
🔵 Computed
20231.00đ
WoS Q4(IF: 2.7)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Clin Exp Vaccine Res, the official English journal of the Korean Vaccine Society, is an international, peer reviewed, and open-access journal. It covers all areas related to vaccines and vaccination. Clin Exp Vaccine Res publishes editorials, review articles, special articles, original articles, case reports, brief communications, and correspondences covering a wide range of clinical and experimental subjects including vaccines and vaccination for human and animals against infectious diseases caused by viruses, bacteria, parasites and tumor. The scope of the journal is to disseminate information that may contribute to elaborate vaccine development and vaccination strategies targeting infectious diseases and tumors in human and animals. Relevant topics range from experimental approaches to (pre)clinical trials for the vaccine research based on, but not limited to, basic laboratory, translational, and (pre)clinical investigations, epidemiology of infectious diseases and progression of all aspects in the health related issues. It is published printed and open accessed online issues (https://ecevr.org) two times per year in 31 January and 31 July. Clin Exp Vaccine Res is linked to many international databases and is made freely available to institutions and individuals worldwide

Topics Covered (Recognized by AI)
Medicine99.6%Biology98.1%Immunology89.5%Virology87.3%Genetics82.4%Pathology80.9%Internal medicine61.8%Antibody58.8%Vaccination53.9%Immune system52.8%Antigen52.4%Chemistry48.3%Virus46.4%Biochemistry45.3%Gene31.5%Immunization29.6%Disease29.2%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #14,108Scopus Q3Diamond OASCImago Profile
Scopus Coverage:2017-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q3
0.404

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q3
Scopus H-Index (2025)
25

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
1.32

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
100% Free

Diamond Open Access: Authors publish completely free of charge with zero author-facing fees.

Diamond Open Access

Scopus 3-Year Publication & Citation Window

3-Year Citations182
3-Year Documents118
Citable Documents108

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Immunology and AllergyQ3
Infectious DiseasesQ3
PharmacologyQ3
Public Health, Environmental and Occupational HealthQ3

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Gold OA
OA publishing option or traditional subscription
Publisher
Seoul : Korean Vaccine Society
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusDOAJPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
IMMUNOLOGY
JCRESCI
166/183Q4
IMMUNOLOGY
JCIESCI
167/183Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—102
20251.34756
20242.138122
20232.742140
2022—39330
2021—40511
2020—24300
2019—18269
2018—18436
2017—21677
2016—26340
2015—261,018
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Clinical and Experimental Vaccine Research

WoS Q4
01342023202420251.30
Annual Impact Factor Metric
2025:1.3

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: ffa371d1-5e56-41ab-b189-367fc4207f06
Database Updated: 2026-10-01